Gerd
Mar 27, 2008
Orexo announces results confirming the clinical profile of OX17 in reflux disease
Regulatory News: New clinical data from a phase II study confirms the competitive profile of Orexo ' s product OX17 in GERD patients, i.e. fast, effective and sustained inhibition of gastric acid production, a ... via Business Wire
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| got cure for acid reflux (from Jan '07) | Apr 25 | Max | 19 |
| Dr. Scott Eller - Family Physcian (from Oct '07) | Oct '07 | Neil Warner | 1 |
| Does GERD Exacerbate COPD? (from Dec '06) | Jul '07 | star | 2 |
| asdas (from May '06) | Nov '06 | test | 2 |
| Weight gain could raise the risk of heartburn i... (from Jul '06) | Jul '06 | Nancy | 1 |
